---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255124646.md"
description: "A-share innovative drug concept stocks rose again, with Chemexpress, HitGen, and Medicilon increasing by over 10%, while Bide and WuXi AppTec also followed suit"
datetime: "2025-08-29T05:12:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255124646.md)
  - [en](https://longbridge.com/en/news/255124646.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255124646.md)
---

# 

A-share innovative drug concept stocks rose again, with Chemexpress, HitGen, and Medicilon increasing by over 10%, while Bide and WuXi AppTec also followed suit

### Related Stocks

- [688222.CN](https://longbridge.com/en/quote/688222.CN.md)
- [688202.CN](https://longbridge.com/en/quote/688202.CN.md)
- [603259.CN](https://longbridge.com/en/quote/603259.CN.md)
- [02359.HK](https://longbridge.com/en/quote/02359.HK.md)
- [688073.CN](https://longbridge.com/en/quote/688073.CN.md)
- [688131.CN](https://longbridge.com/en/quote/688131.CN.md)

## Related News & Research

- [WuXi AppTec declares 2026 mid-year dividend of RMB 5.1 per 10 shares](https://longbridge.com/en/news/294669177.md)
- [13:34 ETEZ Texting Launches AI Assistants for SMS Marketing: Send texts, run campaigns using ChatGPT, Claude or any famous AI Tool](https://longbridge.com/en/news/294854848.md)
- [Latigo, BlossomHill launch US IPOs as biotech listings rebound](https://longbridge.com/en/news/294692625.md)
- [Nipro affiliate Spryte Medical completes enrollment in INSYTE pivotal nOCT aneurysm imaging trial](https://longbridge.com/en/news/294776690.md)
- [Biovica says Clinical Cancer Research study links low DiviTum TKa levels to early benefit in advanced breast cancer trial](https://longbridge.com/en/news/294781247.md)